In glioblastoma patients, the AC003092.1 showed a positive correlation with the gene expression of its predicted target gene TFPI2 (tissue factor pathway inhibitor 2) (Figure 2D, Spearman r = 0.6, p < 0.001). The gene discussed is TFPI2; the disease is glioblastoma.